ERFSF (Eurofins Scientific SE) Long-Term Debt: $3,990 Mil (As of Dec. 2025)


ERFSF Eurofins Scientific SE ERFSF
80 GF Score
Price $76.48
GF Value $77.44
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Eurofins Scientific SE Long-Term Debt?

Eurofins Scientific SE ERFSF 80 Long-Term Debt is $3,990 Mil as of Dec. 2025. GuruFocus rates ERFSF with a GF Score™ of 80/100 and a GF Value™ of $77.44 (Fairly Valued). The stock has 7 warning signs investors should review.

Eurofins Scientific SE's Long-Term Debt for the quarter that ended in Dec. 2025 was $3,990 Mil.

Eurofins Scientific SE's quarterly Long-Term Debt increased from Dec. 2024 ($2,800 Mil) to Jun. 2025 ($3,659 Mil) and increased from Jun. 2025 ($3,659 Mil) to Dec. 2025 ($3,990 Mil).

Eurofins Scientific SE's annual Long-Term Debt declined from Dec. 2023 ($3,151 Mil) to Dec. 2024 ($2,800 Mil) but then increased from Dec. 2024 ($2,800 Mil) to Dec. 2025 ($3,990 Mil).

Eurofins Scientific SE  (OTCPK:ERFSF) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Eurofins Scientific SE Long-Term Debt Related Terms

Eurofins Scientific SE Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Eurofins Scientific SE's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eurofins Scientific SE Long-Term Debt Chart

Eurofins Scientific SE Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,352.54 2,873.73 3,150.93 2,800.21 3,989.70

Eurofins Scientific SE Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,150.93 3,130.57 2,800.21 3,658.71 3,989.70
ERFSF
80GF Score
Eurofins Scientific SE ERFSF
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of $3,990 Mil mean?
Eurofins Scientific SE (ERFSF) has a Long-Term Debt of $3,990 Mil as of Dec. 2025.
Is Eurofins Scientific SE's Long-Term Debt too high?
Eurofins Scientific SE's current Long-Term Debt is $3,990 Mil. Overall, Eurofins Scientific SE has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Eurofins Scientific SE's Long-Term Debt compare to TMO and DHR?
Eurofins Scientific SE's Long-Term Debt of $3,990 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Medical Diagnostics & Research company?
A good Long-Term Debt depends on the Medical Diagnostics & Research industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Eurofins Scientific SE's current Long-Term Debt is $3,990 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eurofins Scientific SE stock overvalued right now?
Based on GuruFocus' analysis, Eurofins Scientific SE (ERFSF) is currently considered Fairly Valued. The stock's GF Value™ is $77.44, compared to a current price of $76.48 — trading 1.2% below its estimated fair value. The current Long-Term Debt is $3,990 Mil. Eurofins Scientific SE's overall GF Score™ is 80/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Eurofins Scientific SE (ERFSF), the current Long-Term Debt is $3,990 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Eurofins Scientific SE (ERFSF) Overvalued in 2026?

Based on GuruFocus' analysis, Eurofins Scientific SE stock appears to be undervalued. The current stock price of $76.48 is trading 1.2% below its estimated GF Value™ of $77.44. GuruFocus considers Eurofins Scientific SE to be Fairly Valued.

Key valuation signals for ERFSF:

  • Long-Term Debt: $3,990 Mil
  • GF Value™: $77.44 vs. price of $76.48 (1.2% below fair value)
  • GF Score™: 80/100 with 7 warning signs

No single metric tells the full story. See the ERFSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Eurofins Scientific SE Business Description

Address 23 Val Fleuri, Luxembourg, LUX, 1526
Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services. These include tests to evaluate the safety, identity, composition, authenticity, purity, origin, and traceability of various biological substances and products. Eurofins operates over 950 laboratories in 61 countries. Its revenue from Europe, North America, and the rest of the world contributes approximately 50%, 40%, and 10% of total revenue, respectively. Its areas of business activity are food, feed, and environmental testing ("life"), biopharmaceutical services, diagnostic services and products, and consumer and technology products testing, which contribute approximately 40%, 30%, 20%, and 10% respectively.
80GF Score

Get the complete analysis for ERFSF

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$76.48
Price
$77.44
GF Value